Merck (HAM:6MK) Accounts Payable & Accrued Expense : €20,260 Mil (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Merck Accounts Payable & Accrued Expense?

Merck's quarterly accounts payable & accrued expense increased from Sep. 2023 (€20,808 Mil) to Dec. 2023 (€22,303 Mil) but then declined from Dec. 2023 (€22,303 Mil) to Mar. 2024 (€20,260 Mil).

Merck's annual accounts payable & accrued expense increased from Dec. 2021 (€18,992 Mil) to Dec. 2022 (€21,045 Mil) and increased from Dec. 2022 (€21,045 Mil) to Dec. 2023 (€22,303 Mil).

Merck Accounts Payable & Accrued Expense Historical Data

The historical data trend for Merck's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Accounts Payable & Accrued Expense Chart

Merck Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

16,749.00

16,283.82

18,992.10

21,044.59

22,303.27

Merck Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															19,108.71	18,972.27	20,807.96	22,303.27	20,260.24

Merck Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Merck (HAM:6MK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (HAM:6MK) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

MRK:USA MRK:Peru MRK:Mexico 1MRKX:Italy 6MKd:UK 0QAH:UK 6MK:Germany 6MK:Germany 6MK:Germany MRK:Chile MRCK34:Brazil MRK:Austria MRK:Argentina

Address

126 East Lincoln Avenue, Rahway, NJ, USA, 07065

Website

https://www.merck.com

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Merck (HAM:6MK) Headlines

No Headlines